which is more effective for weight loss semaglutide or tirzepatide GLP-1 Medications Loss: vs vs Retat – Revolution Health & Wellness Tirzepatide vs Semaglutide: Key Differences

After the FDA approved an oral version of Wegovy in late 2025, the first GLP-1 receptor agonist pill designed to treat obesity, expectations were high

"Wegovy is a once-weekly injection approved by the FDA in 2021 for chronic weight management

Lower concentrations including 1.0 mg weekly generated clinically meaningful results approaching 10-11% weight reduction in study populations

As these medications become more widely used, fitness and wellness professionals must understand not only the science behind them, but how to coach clients through the real-world challenges and opportunities they present

Yesrotating sites is highly recommended

Unlike previous medications that target only one hormonal pathway, tirzepatide's dual mechanism reduces appetite and slows digestion, helping you to feel full longer